Cargando…
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin
INTRODUCTION: Apolipoprotein C-III (Apo CIII) is a crucial regulator of triglyceride-rich lipoproteins (TRLs) and influences the risk of cardiovascular diseases. High levels of Apo CIII have been also associated with cerebrovascular events and earlier works showed procoagulant effects of Apo CIII. T...
Autores principales: | Olivieri, Oliviero, Turcato, Gianni, Cappellari, Manuel, Stefanoni, Filippo, Osti, Nicola, Pizzolo, Francesca, Friso, Simonetta, Bassi, Antonella, Castagna, Annalisa, Martinelli, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854278/ https://www.ncbi.nlm.nih.gov/pubmed/35187103 http://dx.doi.org/10.3389/fcvm.2021.781383 |
Ejemplares similares
-
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII
por: Olivieri, Oliviero, et al.
Publicado: (2019) -
Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events
por: Mango, Gabriele, et al.
Publicado: (2022) -
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013) -
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease
por: Pizzolo, Francesca, et al.
Publicado: (2021) -
Urinary extracellular vesicles carry valuable hints through mRNA for the understanding of endocrine hypertension
por: Friso, Simonetta, et al.
Publicado: (2023)